Related Experiment Videos
[Percutaneous ethanol injection therapy for small hepatocellular carcinoma]
1First Department of Internal Medicine, Toho University School of Medicine.
Summary
Surgical resection is rarely recommended for hepatocellular carcinoma due to recurrence risks. Percutaneous ethanol injection therapy offers excellent local control and preserves liver function for small liver cancers.
Area of Science:
- Hepatobiliary medicine
- Oncology
- Interventional radiology
Context:
- Hepatocellular carcinoma (HCC) management is challenging due to multifocal disease and cirrhosis.
- High recurrence rates (70-90%) post-surgical resection necessitate alternative treatments.
- Small HCC requires effective, function-sparing therapeutic options.
Purpose:
- To evaluate the efficacy and long-term outcomes of percutaneous ethanol injection (PEI) for small hepatocellular carcinoma.
- To establish PEI as a primary treatment modality for select HCC cases.
Summary:
- Percutaneous ethanol injection (PEI) demonstrates excellent local control for small hepatocellular carcinoma.
- PEI effectively preserves overall liver function compared to aggressive surgical interventions.
- This therapy allows for repeat treatments if necessary, enhancing long-term management.
Impact:
- PEI offers a viable, less invasive treatment for small HCC, improving patient outcomes.
- Establishes PEI as a potential first-line therapy, reducing reliance on high-risk surgery.
- Provides a durable treatment option with good long-term results for liver cancer patients.